Dr. Loren K. Mell (@drlorenmell) 's Twitter Profile
Dr. Loren K. Mell

@drlorenmell

Tenured Professor | Co-Director, Hanna & Mark Gleiberman Center | Vice Chair, Clinical & Translational Research | UC San Diego Dept. of Radiation Medicine

ID: 360338556

linkhttps://profiles.ucsd.edu/loren.mell calendar_today23-08-2011 01:57:31

477 Tweet

1,1K Followers

845 Following

CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

At the time of post-hoc extended analysis, with a median follow-up of 2.3 years, 2-year PFS was 50.6% in the durvalumab group (95% CI, 41.5%-59.8%) and 63.7% in the cetuximab group (95% CI, 51.3%-76.1%). #hncsm | Dr. Loren K. Mell cancernetwork.com/view/durvaluma…

ACRO - American College of Radiation Oncology (@acroradonc) 's Twitter Profile Photo

☢️ #ACRO2025 moderator Anna Lee shares a sneak peek at the Head & Neck session with speakers Dr. Loren K. Mell & @jessschuster! Don't forget: early bird registration ends Friday! 🐦 #ACROinVegas #AcingCancerCare

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

In patients with locally advanced hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) combined with sorafenib improved progression-free survival and showed a clinically important improvement in overall survival compared to sorafenib alone. ja.ma/3VKXCQl

In patients with locally advanced hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) combined with sorafenib improved progression-free survival and showed a clinically important improvement in overall survival compared to sorafenib alone. ja.ma/3VKXCQl
Parisa Shams (@p_shams_) 's Twitter Profile Photo

Announcing NRG-CC014 (PREEMPT) by Dr. Gillespie! 📢 A Phase 3 trial exploring radiation therapy for high-risk asymptomatic bone metastases. A step forward in innovative cancer care! Erin Gillespie, MD MPH #radonc NRG Oncology RTOG Foundation #NRG2025

Announcing NRG-CC014 (PREEMPT) by Dr. Gillespie! 📢 

A Phase 3 trial exploring radiation therapy for high-risk asymptomatic bone metastases. A step forward in innovative cancer care! 

<a href="/ErinGillespieMD/">Erin Gillespie, MD MPH</a> 
#radonc 
<a href="/NRGonc/">NRG Oncology</a> <a href="/RTOGFoundation/">RTOG Foundation</a> 
#NRG2025
Yakup Ergün (@dr_yakupergun) 's Twitter Profile Photo

Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC Pooled analysis of 3 RCTs 💥Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC

Pooled analysis of 3 RCTs

💥Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC
 acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
John Asghar MD (@jahangirasgha10) 's Twitter Profile Photo

60 hours. That’s how much administrative work is generated per U.S. physician, every single week. Roughly 9 hours by the doctor, and 50+ hours by staff — just to keep up with the bureaucracy. That’s 60 hours not directed toward patient care. No other developed country comes

60 hours.
That’s how much administrative work is generated per U.S. physician, every single week.

Roughly 9 hours by the doctor, and 50+ hours by staff — just to keep up with the bureaucracy.

That’s 60 hours not directed toward patient care.

No other developed country comes
Dr. Loren K. Mell (@drlorenmell) 's Twitter Profile Photo

C-POST trial results showing significant DFS advantage to adjuvant cemiplimab following surgery and RT for high risk cSCC, well done! Results published in NEJM

C-POST trial results showing significant DFS advantage to adjuvant cemiplimab following surgery and RT for high risk cSCC, well done! Results published in NEJM
Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo

What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72

What if this was  a drug  ?🙂 

🆕 NEJM | June 2025
🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer
📦 RCT | n=889 | Median FU: 7.9 yrs
🟠 3-yr structured aerobic program vs health ed alone
📈 Primary Endpoint: Disease-Free Survival (DFS)
🔹 HR 0.72
Kathryn Ries Tringale (@kathryntringale) 's Twitter Profile Photo

Amazing work Bea Fregonese presenting our initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke

Amazing work <a href="/fregonese_bea/">Bea Fregonese</a> presenting our initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. 
There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke
Dr. Loren K. Mell (@drlorenmell) 's Twitter Profile Photo

Get ready for a good clubbing! Sign up for the 3rd annual KASTRO Dynamic Wedge Invitational Sep 28 at the Presidio in SF today! No need to be good at golf or even have friends- you can make them there! koreanastro.org/golf-tournamen…